Clinical trials are currently ongoing to study metformin in early breast cancertreatment and have demonstrated the benefit of metformin in the treatment of prostate, pancreatic, and livercancer.
When, nine months after diagnosis, Jobs finally abandoned alternative treatment and agreed to surgery, his cancer had spread to the liver, dramatically reducing his survival chances.